Eva Moreno-Monterde

Eva Moreno-Monterde

Auto-generated profile, based on publicly available information

Eva Moreno-Monterde

Fundació Clinic Per la Recerca Biomèdica Institute d'Investigacions Biomèdiques August Pi i Sunyer (FCRB‐IDIBAPS) Barcelona Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2025 in Heart, Lung and Circulation
Verified
Journal Article
Open access
RARut Andrea
Rut Andrea
MIMarc Izquierdo-Ribas
Marc Izquierdo-Ribas
ESEsther Sanz
Esther Sanz
CGCosme Garcia-Garcia
Cosme Garcia-Garcia
ASAntonia Sambola
Antonia Sambola
PLPablo Loma-Osorio
Pablo Loma-Osorio
Out-of-hospital cardiac arrest (OHCA) remains a leading cause of cardiovascular mortality, yet significant gaps persist in understanding how contemporary management strategies influence long-term outcomes. We sought to provide novel insights into the characteristics, management variability, and 6-month outcomes of patients with OHCA admitted to eight intensive cardiovascular care units during a contemporary period. This was a prospective multicentre registry of patients with OHCA admitted to intensive cardiovascular care units from October 2020 to December 2021. Patients were categorised by prognosis as either favourable outcome (Cerebral Performance Category [CPC] 1-2) or non-favourable outcome, including death (CPC 3-5). A multinomial logistic regression identified independent predictors of CPC 3-5. Among 288 patients, only 17.36% were women. Most arrests (88.93%) were witnessed, yet bystander cardiopulmonary resuscitation was initiated in just 69.18% of cases. Despite 80% of patients presenting with a shockable rhythm, an automated external defibrillator was used in only 58%. Median time to return of spontaneous circulation (ROSC) was 28 minutes. Marked variability in post-resuscitation care was observed across centres in the use of targeted temperature management, emergent coronary angiography, and multimodal neuroprognostication. At 6 months, 49% of patients exhibited CPC 1-2. Ninety-three per cent of discharged patients maintained a favourable neurological outcome, and 15% improved their CPC score. Independent predictors of CPC 3-5 included older age (p=0.005), male sex (p=0.016), previous stroke (p=0.046), prolonged time to ROSC (p<0.001), and a non-shockable initial rhythm (p<0.001). Hypoxic-ischaemic brain injury was the leading cause of in-hospital death (72.90%). Nearly half of the patients with OHCA survived with a favourable neurological outcome, which persisted after 6 months. Despite significant in-hospital interventions, pre-hospital factors remained the strongest predictors of neurological outcome. The high degree of management variability suggests an urgent need for standardised protocols and supports the creation of cardiac arrest centres.

20 August 2026 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FTFrancisco Rafael Jimenez Trinidad
Francisco Rafael Jimenez Trinidad
EMEva Moreno‐Monterde
Eva Moreno‐Monterde
CRCarlos Roca‐Guerrero
Carlos Roca‐Guerrero
ODOriol de Diego
Oriol de Diego
TLTeresa López‐Sobrino
Teresa López‐Sobrino
RARut Andrea
Rut Andrea
Background: Early neuroprognostication in Out‐of‐Hospital Cardiac Arrest (OHCA) remains challenging due to the lack of reliable biomarkers. Circulating microRNAs have emerged as potential indicators of inflammation and brain injury (HIBI). This study aimed to evaluate whether in silico‐predicted microRNAs could discriminate neurological outcomes early in OHCA patients. Methods: Consecutive OHCA patients admitted to the Acute Cardiac Care Unit with available cryopreserved blood samples were analysed. Neurological outcome was classified into favourable (Cerebral Performance Category (CPC) 1–2) and unfavourable (CPC 3–5). Blood samples at 0, 24, 72 h after hospital admission were collected. An in silico‐derived network of inflammation‐HIBI‐related microRNA was generated and validated in all patients at the three time‐points. Results: A total of 100 patients were included (59.7 ± 12.5 years, 19% women). 53% had unfavourable neurological outcomes. Eleven candidate microRNAs were identified, showing differential time‐dependent expression within 72 h. The earlier and most predictive microRNAs for unfavourable neurological outcome were miR‐1‐3p (AUC 0.637) and miR‐124‐3p (AUC 0.606) at 0 h, miR‐21‐5p (AUC 0.614) and miR‐499a‐5p (AUC 0.645) at 24 h. The miR‐499‐5p maintained the best AUC across all time‐points. A multiparametric model achieved an AUC of 0.690. A pro‐inflammatory environment, characterised by C‐Reactive Protein (CRP) and neutrophil‐to‐lymphocyte ratio, showed distinct temporal expression patterns regarding neurological outcome. Neuroinflammatory miR‐let‐7a‐5p, miR‐23a‐3p and miR‐146a‐5p were significantly overexpressed in the unfavourable group and correlated positively with CRP. Conclusions: In silico derived inflammatory and HIBI‐related microRNAs showed time‐dependent expression patterns that may distinguish neurological outcomes within 72 h after OHCA.